Development of Pandemic Vaccines: ERVEBO Case Study

Development of Pandemic Vaccines: ERVEBO Case Study

Preventative vaccines are considered one of the most cost-effective and efficient means to contain outbreaks and prevent pandemics. However, the requirements to gain licensure and manufacture a vaccine for human use are complex, costly, and time-consuming. The 2013–2016 Ebola virus disease (EVD) out...

Full description

Bibliographic Details
Main Authors: Jayanthi Wolf, Risat Jannat, Sheri Dubey, Sean Troth, Matthew T. Onorato, Beth-Ann Coller, Mary E. Hanson, Jakub K. Simon
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Vaccines
Subjects:
<i>Ebolavirus</i> vaccine
rVSVΔG-ZEBOV-GP
vaccine development
regulatory strategy
vaccine manufacturing
Online Access:https://www.mdpi.com/2076-393X/9/3/190

Internet

https://www.mdpi.com/2076-393X/9/3/190

Similar Items